Literature DB >> 17960228

Cancer: mixing cocktails.

Charles L Sawyers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17960228     DOI: 10.1038/449993a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  25 in total

1.  Targeted cancer therapy: what if the driver is just a messenger?

Authors:  Jonathan H Schatz; Hans-Guido Wendel
Journal:  Cell Cycle       Date:  2011-11-15       Impact factor: 4.534

2.  Targeted cancer therapies.

Authors:  Saurabh Aggarwal
Journal:  Nat Rev Drug Discov       Date:  2010-06       Impact factor: 84.694

3.  Optimization of drug combinations using Feedback System Control.

Authors:  Patrycja Nowak-Sliwinska; Andrea Weiss; Xianting Ding; Paul J Dyson; Hubert van den Bergh; Arjan W Griffioen; Chih-Ming Ho
Journal:  Nat Protoc       Date:  2016-01-14       Impact factor: 13.491

4.  Closed-loop control of cellular functions using combinatory drugs guided by a stochastic search algorithm.

Authors:  Pak Kin Wong; Fuqu Yu; Arash Shahangian; Genhong Cheng; Ren Sun; Chih-Ming Ho
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-20       Impact factor: 11.205

5.  Automatic optimization of drug cocktails on an integrated microfluidic system.

Authors:  Wen-Yen Huang; Ching-An Liu; Rong-Syuan Fan; Zhi-Da Lin; Kuan Wang; Gwo-Bin Lee
Journal:  Biomicrofluidics       Date:  2017-05-15       Impact factor: 2.800

Review 6.  Personalized therapies in the cancer "omics" era.

Authors:  Alberto Ocaña; Atanasio Pandiella
Journal:  Mol Cancer       Date:  2010-07-29       Impact factor: 27.401

7.  Molecular interactions of ErbB1 (EGFR) and integrin-β1 in astrocytoma frozen sections predict clinical outcome and correlate with Akt-mediated in vitro radioresistance.

Authors:  Miklós Petrás; Tamás Lajtos; Elza Friedländer; Almos Klekner; Eva Pintye; Burt G Feuerstein; János Szöllosi; György Vereb
Journal:  Neuro Oncol       Date:  2013-04-17       Impact factor: 12.300

8.  A predictive phosphorylation signature of lung cancer.

Authors:  Chang-Jiun Wu; Tianxi Cai; Klarisa Rikova; David Merberg; Simon Kasif; Martin Steffen
Journal:  PLoS One       Date:  2009-11-25       Impact factor: 3.240

9.  Protein modifications as potential biomarkers in breast cancer.

Authors:  Hongjun Jin; Richard C Zangar
Journal:  Biomark Insights       Date:  2009-11-30

10.  Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases.

Authors:  Beth Apsel; Jimmy A Blair; Beatriz Gonzalez; Tamim M Nazif; Morri E Feldman; Brian Aizenstein; Randy Hoffman; Roger L Williams; Kevan M Shokat; Zachary A Knight
Journal:  Nat Chem Biol       Date:  2008-10-12       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.